Get Premium to unlock powerful stock data
NAS:TRDA (USA)  
Entrada Therapeutics Inc logo

Entrada Therapeutics Inc

$ 9.81 +0.36 (+3.81%) 10:08 PM EST
P/E:
At Loss
P/B:
1.11
Market Cap:
$ 307.70M
Enterprise V:
$ 75.65M
Volume:
1.21M
Avg Vol (2M):
101.95K
Volume:
1.21M
Market Cap $:
307.70M
PE Ratio:
At Loss
Avg Vol (2-Month):
101.95K
Enterprise Value $:
75.65M
PB Ratio:
1.11
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Entrada Therapeutics Inc
NAICS : 325412 SIC : 2834
6 Tide Street, Boston, MA, USA, 02210
Description
Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 8.28
Equity-to-Asset 0.88
Debt-to-Equity 0.12
Debt-to-EBITDA -0.5
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 72.65
9-Day RSI 69.16
14-Day RSI 65.87
6-1 Month Momentum % -64.75

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 17.68
Quick Ratio 17.68
Cash Ratio 17.11

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
ROE % -58
ROA % -28.69
ROIC % -300.89
ROC (Joel Greenblatt) % -446.51
ROCE % -30.02

Financials (Next Earnings Date:2022-08-15 Est.)

TRDA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:TRDA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -2.578
Beta 0
Volatility % 0
14-Day RSI 65.87
14-Day ATR ($) 1.269206
20-Day SMA ($) 8.18425
12-1 Month Momentum % 0
52-Week Range ($) 5.12 - 36.85
Shares Outstanding (Mil) 31.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Entrada Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More